Bioray Pharmaceutical Co., Ltd.

This was a very early, small study to test the safety of a new drug called BR101 in people with advanced solid tumors that had stopped responding to standard treatments. The main goal was to find a safe dose for future studies by giving the drug to 15 participants and closely mon…